| Literature DB >> 35898953 |
Amare Zewdie1, Ayenew Mose2, Tadesse Sahle3, Jemal Bedewi1, Molla Gashu1, Natnael Kebede4, Ali Yimer5.
Abstract
Objective: The health belief model specifies that individuals' perceptions about particular behavior can predict the performance of respective behavior. So far, the model has been used to explain why people did not follow COVID-19 preventive behavior. Although we are using it, to our best knowledge, its predictive ability in COVID-19 preventive behavior is unexplored. So, this review aimed to assess the model's predictive ability and identify the most frequently related construct. Method: A systematic review was conducted to examine the predictive ability of health belief model in COVID-19 preventive behavior using research done all over the world. Preferred reporting items for systematic review and meta-analysis guidelines were used. Comprehensive literature was searched using databases such as PubMed, Google scholar, and African Online Journal to retrieve related articles. Descriptive analyses such as the proportion of studies that better explained COVID-19 prevention behavior and the significance ratio of each construct of the model were made. Result: Overall, 1552 articles were retrieved using a search strategy and finally 32 articles fulfilling the inclusion criteria undergo the review. We found that in the majority (87.5%) of the studies health belief model has a good predictive ability of COVID-19-related behavior. Overall the explained variance for health belief model ranged from 6.5% to 90.1%. The perceived benefit was the most frequently significant predictor; highest significance ratio (96.7%) followed by self-efficacy, cues to action perceived barrier, susceptibility, and severity in decreasing order.Entities:
Keywords: COVID-19 preventive behavior; Health belief model; predictive ability; systematic review
Year: 2022 PMID: 35898953 PMCID: PMC9310284 DOI: 10.1177/20503121221113668
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Figure 1.Conceptual framework of the health belief model.
Figure 2.Flow chart of study selection for systematic review on predicting ability of the health belief model in COVID-19 preventive behavior.
Study characteristics, proportion variance, and type of COVID-19 related behavior explained in included studies in the systematic review 2022.
| Authors | Year | Country | Sample size | Analysis model fitted | The proportion of variance explained | Type of COVID-19 preventive behavior |
|---|---|---|---|---|---|---|
| Le An et al.
| 2021 | Vietnam | 462 | HLoR | 30% (Cox and Snell) | Vaccine acceptance |
| Shmueli L.
| 2021 | Israeli | 398 | HLoR | 74% (Cox and Snell) | Vaccination intention |
| Karimy et al.
| 2021 | Iran | 1090 | MLR | 27% | Prevention practice |
| Zampetakis and Melas
| 2021 | Greece | 1006 | MLMA | 59% | Vaccination intention |
| Tong KKit et al
| 2020 | China | 616 | MLR | 6.5% | Face masking |
| Patwary et al
| 2021 | Bangladeshi | 639 | HLoR | 21%(Cox and Snell) | Vaccine acceptance |
| Almazyad et al.
| 2021 | Saud Arabiya | 135 | MLR | 65% | Prevention practice |
| Barakat and Kasemy
| 2020 | Egypt | 182 | MLR | 58.4% | Prevention practice |
| Cervera-Torres et al.
| 2021 | Spain | 325 | MLR | 28% | intention to self-isolate |
| González-Castro et al
| 2021 | Spain | 757 | Path analysis | 35% | Prevention practice |
| Hossain et al.
| 2021 | Bangladesh | 1,497 | MLR | 31% | vaccine hesitancy |
| Mirakzadeh et al.
| 2021 | Iran | 80 | SEM | 56% | Prevention practice |
| Moghadam et al.
| 2022 | Iran | 304 | SEM | 59% | Prevention practice |
| Kim and Kim
| 2020 | Korea | 1525 | MLR | 27.7% | Prevention practice |
| Wang, Zhao, and Fan
| 2021 | China | 337 | HLR | 25.6% | willingness to wear masks |
| Yan et al.
| 2021 | China | 1255 | HLR | 38.2% | Adherence to prevention measure |
| Noghabi, Ali Delshad, et al.
| 2021 | Iran | 1,020 | MLR | 51.1% | Prevention practice |
| Mirzaei et al.
| 2021 | Iran | 558 | MLR | 29.3% | Prevention practice |
| Al-Metwali et al.
| 2021 | Iraq | 1680 | MLR | 67.8% | Vaccine acceptance |
| Badr et al.
| 2021 | USA | 2222 | MLR | 15% | Adherence to prevention measure |
| Fathian-Dastgerdi, Tavakoli, and Jaleh
| 2021 | Iran | 797 | HLR | 46% | Prevention practice |
| Suess et al.
| 2022 | USA | 1478 | SEM | 46.6% | Willingness to vaccinate |
| Mahindarathne, Prasad
| 2021 | Sri Lanka | 307 | MLR | 48.7% | Prevention practice |
| Mercadante and Law
| 2021 | USA | 525 | Path analysis | 13% | Decision-making determinant to vaccinate |
| Ellithorpe et al.
| 2022 | USA | 682 | MLR | 62% | Intention to vaccinate |
| Tsai et al.
| 2021 | Taiwan | 361 | HLR | 58.1% | Behavioral intention to practice |
| Handebo et al.
| 2021 | Ethiopia | 301 | MLR | 54% | Intention to vaccinate |
| Zuo et al.
| 2021 | China | 342 | HLR | 90.1% | Prevention practice |
| Hansen et al.
| 2021 | USA | 425 | MLR | 41% | Social distancing |
| Mehanna, Elhadi, Lucero-Prisno
| 2021 | Sudan | 680 | MLR | 43.4% | Adherence to prevention measure |
| Kamran et al.
| 2021 | Iran | 1861 | MLR | 54.7% | Adherence to prevention measure |
| Rosental and Shmueli
| 2021 | Israel | 628 | HLoR | 66% | Vaccine acceptance |
HLoR: hierarchical logistic regression; MLR: multiple linear regression; HLR: hierarchical linear regression; MLMA: multilevel modeling analyses; SEM: structural equation modeling.
Significance ratio of HBM constructs with COVID-19-related behavior of each included studies in the systematic review 2022.
| Authors | Statistically significant at ( | |||||
|---|---|---|---|---|---|---|
| Perceived susceptibility | Perceived severity | Perceived benefit | Perceived barrier | Self-efficacy | Cues to action | |
| An PL, et al.
| OR 2.3 | With Ps | 1.8 | – | NI | 8.5 |
| Shmueli L.
| – | OR = 2.36 | 4.49 | – | 1.82 | 1.99 |
| Karimy M, et al.
| – | β = 0.079 | 0.105 | −0.182 | NI | 0.252 |
| Zampetakis LA and Melas C
| b = −0.16 | 0.29 | 0.37 | −0.31 | NI | NI |
| Tong KK, et al
| – | – | β 0.08 | – | NI | – |
| Patwary MM, et al
| OR = 1.78 | – | 2.00 | 0.49 | NI | 2.05 |
| Almazyad, EM, et al.
| β = 0.378 | – | 0.156 | – | – | – |
| Barakat AM and Kasemy ZA.
| β = 0.162 | – | 0.239 | −0.131 | 0.158 | – |
| Cervera-Torres S, et al.
| – | – | β −0.138 | – | −0.190 | NI |
| González-Castro JL, et al
| b = 0.14 | 0.65 | NI | NI | – | NI |
| Hossain MB, et al.
| β = −0.06 | −0.11 | −0.33 | 0.30 | NI | – |
| Mirakzadeh AA, et al.
| β = 0.34 | 0.16 | 0.33 | – | 0.19 | 0.09 |
| Moghadam MT, et al.
| – | β = 0.18 | 0.14 | – | 0.14 | 0.35 |
| Kim S and Kim S.
| β = −0.06 | 0.12 | 0.04 | – | 0.23 | 0.08 |
| Wang M, Zhao C and Fan J.
| β = 0.12 | NI | 0.10 | −0.14 | NI | NI |
| Yan E, et al.
| – | NI | 0.10 | −0.05 | 0.07 | 0.17 |
| Noghabi A, et al.
| β = 0.10 | 0.14 | 0.33 | −0.20 | 0.23 | 0.09 |
| Mirzaei A, et al.
| – | – | β = 0.19 | −0.25 | 0.30 | NI |
| Al-Metwali BZ, et al.
| – | – | β = 0.37 | 0.17 | NI | 0.15 |
| Badr H, et al.
| b = 0.23 | With Ps | NI | NI | NI | NI |
| Fathian-Dastgerdi Z, Tavakoli B and Jaleh M44 | β = − 0.05 | – | 0.07 | −0.10 | 0.59 | NI |
| Suess C, et al.
| β = .40 | .79 | 0.91 | NI | NI | NI |
| Mahindarathne PP
| – | – | b = 0.40 | −0.1 | 0.405 | NI |
| Mercadante AR and Law AV
| – | – | β = −0.11 | 0.31 | NI | −0.21 |
| Ellithorpe ME, et al.
| – | b = 0.08 | 0.66 | NI | NI | NI |
| Tsai FJ, et al.
| β = 0.09 | – | 0.27 | −0.15 | .48 | – |
| Handebo S, et al.
| β = 0.16 | – | 0.38 | −0.16 | NI | 0.34 |
| Zuo Y, et al.
| b = 0.05 | With Ps | 0.37 | NI | 0.32 | NI |
| Hansen AC, et al.
| b = 0.43 | – | 0.82 | NI | NI | NI |
| Mehanna A, Elhadi YA, Lucero-Prisno DE
| – | b = 0.11 | 0.35 | – | 0.48 | NI |
| Kamran Aziz, et al.
| – | – | – | NI | NI | NI |
| Rosental H and Shmueli L.
| β = 0.06 | – | 0.26 | −0.15 | NI | 0.07 |
| Significance ratio | 59.4% | 40% | 96.7% | 64% | 87.5% | 72.2% |
b: unstandardized coefficient; β: standardized coefficient; NI: not included; Ps; Perceived susceptibility; –means nonsignificant.